"Alarms Sound Over Trump's Proposed Research Rule: A Broad Coalition Unites Against Potential Changes. In a rare display of unity, patient advocacy groups, leading scientists, bipartisan lawmakers, and major pharmaceutical companies are rallying against a proposed rule change by the Trump administration that could significantly impact medical research funding. The proposed rule, which aims to redefine the definition of a 'qualified institutional owner,' has sparked widespread concern that it could limit access to crucial research grants and hinder breakthroughs in life-saving treatments. As the stakes grow higher, lawmakers and experts are urging the administration to reconsider the proposal and protect the integrity of the research process."
Click in for more news from The Hill {beacon} Healthcare Health Care Your feedback matters to us. Take our brief newsletter survey to help us improve the newsletters you read every day. The Big Story Trump's proposed research rule faces pushback Patient groups, scientists, bipartisan lawmakers, pharmaceutical companies and more are all sounding alarms...
